Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study

BACKGROUND: Serum albumin may be used to stratify human immunodeficiency virus (HIV)–infected persons with high CD4 count according to their risk of serious non-AIDS endpoints. METHODS: Cox proportional hazards models were used to analyze the risk of serious non-AIDS events in the Strategic Timing o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Infect Dis
Asıl Yazarlar: Ronit, Andreas, Sharma, Shweta, Baker, Jason V, Mngqibisa, Rosie, Delory, Tristan, Caldeira, Luis, Ndembi, Nicaise, Lundgren, Jens D, Phillips, Andrew N
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Major Articles and Brief Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853310/
https://ncbi.nlm.nih.gov/pubmed/29244111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix350
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller